Article 1 to 1 out of 1 concerning MacroChem Corporation
MacroChem acquires rights to Pexiganan from Genaera(10/08/2007) Broadens late-stage product development portfolio building on lead product candidate EcoNail in Phase 2 trial for onychomycosis MacroChem Corporation announced that it has exercised the option it acquired in July, 2007 to acquire exclusive worldwide license rights for drug uses of pexiganan, a novel, small peptide anti-infective for treatment of patients with mild diabetic ...
Top